Brief: Evolus Expects FY sales USD 180-190 million
08/03/2023 21:23
Mar 8 (Reuters) - Evolus Outlook FY sales USD 180-190 million. * Outlook FY sales growth 21-28% * Q4 adjusted gross margin 69.4% * Q4 gross margin 67.7% * Q4 gross profit USD 29.537 million * Q4 net income USD -13.164 million
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe